考验和苦难 - - 临床试验对儿童的挑战
1Research Institute, Children's Hospital of Philadelphia, Philadelphia.
NEJM evidence
|February 6, 2024
概括
达帕格利弗洛辛在儿童2型糖尿病 (T2D) 的试验中显著改善了血糖控制. 这增加了另一种口服药物选择,用于儿童和青少年的T2D管理.
科学领域:
- 内分泌学 在内分泌学.
- 儿童糖尿病管理管理
背景情况:
- 2型糖尿病 (T2D) 在儿童群体中越来越多地被诊断为糖尿病.
- 有限量的口服抗糖尿病药物已被批准用于患有T2D的儿童和青少年.
- 2000年批准的甲福明是儿童T2D的主要口服疗法.
相关概念视频
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
128
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
128
01:12Hazard Ratio
124
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
124